FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 03:45:43 2024-06-28 pm EDT | ||
| 18.48 EUR | -0.59% |
|
| Current month | -21.66% | ||
| 1 month | -28.34% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-28 | 18.48 | -0.59% |
| 24-06-27 | 18.59 | +19.55% |
| 24-06-26 | 15.55 | -6.49% |
| 24-06-25 | 16.63 | -0.24% |
| 24-06-24 | 16.67 | -9.25% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 03:45 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SH7M2V |
| ISIN | DE000SH7M2V2 |
| Date issued | 2022-03-18 |
| Strike | 69.69 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.07 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 28.2 € |
|---|---|
| Lowest since issue | 0.89 € |
| Spread | 0.17 € |
| Spread % | 0.88% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.53
USD
Average target price
53.19
USD
Spread / Average Target
+28.09%
- Stock Market
- Certificates
- Certificat
